» Articles » PMID: 15976386

Calcium Dependence of Proteinase-activated Receptor 2 and Cholecystokinin-mediated Amylase Secretion from Pancreatic Acini

Overview
Date 2005 Jun 25
PMID 15976386
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic acini secrete digestive enzymes in response to a variety of secretagogues including CCK and agonists acting via proteinase-activated receptor-2 (PAR2). We employed the CCK analog caerulein and the PAR2-activating peptide SLIGRL-NH(2) to compare and contrast Ca(2+) changes and amylase secretion triggered by CCK receptor and PAR2 stimulation. We found that secretion stimulated by both agonists is dependent on a rise in cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) and that this rise in [Ca(2+)](i) reflects both the release of Ca(2+) from intracellular stores and accelerated Ca(2+) influx. Both agonists, at low concentrations, elicit oscillatory [Ca(2+)](i) changes, and both trigger a peak plateau [Ca(2+)](i) change at high concentrations. Although the two agonists elicit similar rates of amylase secretion, the rise in [Ca(2+)](i) elicited by caerulein is greater than that elicited by SLIGRL-NH(2). In Ca(2+)-free medium, the rise in [Ca(2+)](i) elicited by SLIGRL-NH(2) is prevented by the prior addition of a supramaximally stimulating concentration of caerulein, but the reverse is not true; the rise elicited by caerulein is neither prevented nor reduced by prior addition of SLIGRL-NH(2). Both the oscillatory and the peak plateau [Ca(2+)](i) changes that follow PAR2 stimulation are prevented by the phospholipase C (PLC) inhibitor U73122, but U73122 prevents only the oscillatory [Ca(2+)](i) changes triggered by caerulein. We conclude that 1) both PAR2 and CCK stimulation trigger amylase secretion that is dependent on a rise in [Ca(2+)](i) and that [Ca(2+)](i) rise reflects release of calcium from intracellular stores as well as accelerated influx of extracellular calcium; 2) PLC mediates both the oscillatory and the peak plateau rise in [Ca(2+)](i) elicited by PAR2 but only the oscillatory rise in [Ca(2+)](i) elicited by CCK stimulation; and 3) the rate of amylase secretion elicited by agonists acting via different types of receptors may not correlate with the magnitude of the [Ca(2+)](i) rise triggered by those different types of secretagogue.

Citing Articles

Low-Dose Trypsin Accelerates Wound Healing Protease-Activated Receptor 2.

Xiang Y, Jiang Y, Lu L ACS Pharmacol Transl Sci. 2024; 7(1):274-284.

PMID: 38230283 PMC: 10789143. DOI: 10.1021/acsptsci.3c00263.


Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.

Barreto S, Habtezion A, Gukovskaya A, Lugea A, Jeon C, Yadav D Gut. 2020; 70(1):194-203.

PMID: 32973069 PMC: 7816970. DOI: 10.1136/gutjnl-2020-322163.


Necroptosis Is an Important Severity Determinant and Potential Therapeutic Target in Experimental Severe Pancreatitis.

Louhimo J, Steer M, Perides G Cell Mol Gastroenterol Hepatol. 2016; 2(4):519-535.

PMID: 27642624 PMC: 5020563. DOI: 10.1016/j.jcmgh.2016.04.002.


Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis.

Bhatia V, Rastellini C, Han S, Aronson J, Greeley Jr G, Falzon M Am J Physiol Gastrointest Liver Physiol. 2014; 307(5):G533-49.

PMID: 25035110 PMC: 4154118. DOI: 10.1152/ajpgi.00428.2013.


Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis.

Michael E, Kuliopulos A, Covic L, Steer M, Perides G Am J Physiol Gastrointest Liver Physiol. 2013; 304(5):G516-26.

PMID: 23275617 PMC: 3602677. DOI: 10.1152/ajpgi.00296.2012.